Cagrilintide

What Is Cagrilintide?
Cagrilintide is a synthetic peptide designed to mimic amylin, a hormone naturally released by pancreatic beta cells alongside insulin. Amylin contributes to physiological processes involved in satiety, gastric emptying, and glucose regulation. Researchers have investigated cagrilintide both as a standalone peptide and in combination with GLP-1 receptor agonists to better understand complementary metabolic pathways.
Current evidence is based primarily on randomized clinical trials, with additional studies continuing to evaluate its long-term safety and efficacy. (Lau DCW et al., The Lancet, 2021; Novo Nordisk clinical development program.)


Current Research
Research has focused on amylin receptor biology, appetite regulation, metabolic physiology, and combination peptide therapies.
Other Peptides
Any Questions?

Our Happy Clients



A Smarter Way to Source and Save
RPN helps aesthetic and medical clinics reduce costs on injectable weight loss products through a streamlined, plug-and-play purchasing system. Our platform is designed to simplify sourcing, improve efficiency, and support clinics as they grow.
By connecting providers with better pricing opportunities, we make it easier to operate smarter without disrupting existing workflows.
Save With RPN
Take the first step with a free cost analysis tailored to your clinic. Our team will review your current purchasing approach and identify opportunities to reduce expenses and improve efficiency. From there, you can seamlessly schedule a discovery call to explore how RPN fits into your workflow.


.jpg)
.jpg)
.jpg)